Chinese Medicines as an Adjuvant Therapy for Unresectable Hepatocellular Carcinoma during Transarterial Chemoembolization: A Meta-Analysis of Randomized Controlled Trials

Objective. To conduct a comprehensive PRISMA-compliant systematic review and meta-analysis to evaluate the efficacy and safety of Chinese medicines (CMs) as an adjuvant therapy for unresectable HCC during transarterial chemoembolization (TACE). Methods. Main databases were searched up to October 201...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheung, Fan, Wang, Xuanbin, Wang, Ning, Yuen, Man-Fung, Ziea, Tat-chi, Tong, Yao, Wong, Vivian Taam, Feng, Yibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730382/
https://www.ncbi.nlm.nih.gov/pubmed/23956773
http://dx.doi.org/10.1155/2013/487919

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730382/
https://www.ncbi.nlm.nih.gov/pubmed/23956773
http://dx.doi.org/10.1155/2013/487919

Ejemplares similares